Paper36959228
Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses.
Zoepfl M and 4 others. Sci Rep, 2023. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses. Papers, record 36959228. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36959228
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Sea Cucumbers | Major topic |
| Animals | |
| Humans | |
| Sulfates | |
| Anticoagulants | |
| Antiviral Agents | |
| SARS-CoV-2 | |
| Polysaccharides | |
| Heparan Sulfate |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P20 GM130460 | NIGMS NIH HHS | United States | P20GM130460 | PubMed and NIH | NIH RePORTER |
| R03 NS110996 | NINDS NIH HHS | United States | R03NS110996 | PubMed and NIH | NIH RePORTER |
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33864843 | Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus. | Antiviral Res | 2021 | https://conductscience.org/library/papers/33864843 | PubMed |
| 2 | 14996843 | Antithrombin-mediated anticoagulant activity of sulfated polysaccharides: different mechanisms for heparin and sulfated galactans. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14996843 | PubMed |
| 3 | 35627910 | Health, Economic and Social Development Challenges of the COVID-19 Pandemic: Strategies for Multiple and Interconnected Issues. | Healthcare (Basel) | 2022 | https://conductscience.org/library/papers/35627910 | PubMed |
| 4 | 32970989 | SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. | Cell | 2020 | https://conductscience.org/library/papers/32970989 | PubMed |
| 5 | 15660517 | Severe acute respiratory syndrome (SARS): a year in review. | Annu Rev Med | 2005 | https://conductscience.org/library/papers/15660517 | PubMed |
| 6 | 32768974 | Outbreak of COVID-19: An emerging global pandemic threat. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/32768974 | PubMed |
| 7 | 14585636 | Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. | Lancet | 2003 | https://conductscience.org/library/papers/14585636 | PubMed |
| 8 | 36136750 | Anti-SARS-CoV-2 and anticoagulant properties of Pentacta pygmaea fucosylated chondroitin sulfate depend on high molecular weight structures. | Glycobiology | 2023 | https://conductscience.org/library/papers/36136750 | PubMed |
| 9 | 34015720 | Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19). | Carbohydr Res | 2021 | https://conductscience.org/library/papers/34015720 | PubMed |
| 10 | 2658755 | Heparin-induced thrombocytopenia. | Annu Rev Med | 1989 | https://conductscience.org/library/papers/2658755 | PubMed |
| 11 | 26690451 | Marine Non-Glycosaminoglycan Sulfated Glycans as Potential Pharmaceuticals. | Pharmaceuticals (Basel) | 2015 | https://conductscience.org/library/papers/26690451 | PubMed |
| 12 | 30942528 | Marine glycan-based antiviral agents in clinical or preclinical trials. | Rev Med Virol | 2019 | https://conductscience.org/library/papers/30942528 | PubMed |
| 13 | 33173010 | Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives. | J Virol | 2021 | https://conductscience.org/library/papers/33173010 | PubMed |
| 14 | 33265927 | SARS-CoV-2 Inhibition by Sulfonated Compounds. | Microorganisms | 2020 | https://conductscience.org/library/papers/33265927 | PubMed |
| 15 | 8984158 | Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. | J Nat Prod | 1996 | https://conductscience.org/library/papers/8984158 | PubMed |
| 16 | 30200211 | Anticoagulant and Antithrombotic Properties of Three Structurally Correlated Sea Urchin Sulfated Glycans and Their Low-Molecular-Weight Derivatives. | Mar Drugs | 2018 | https://conductscience.org/library/papers/30200211 | PubMed |
| 17 | 22446377 | Sequence determination and anticoagulant and antithrombotic activities of a novel sulfated fucan isolated from the sea cucumber Isostichopus badionotus. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22446377 | PubMed |
| 18 | 18327401 | An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases. | Thromb Haemost | 2008 | https://conductscience.org/library/papers/18327401 | PubMed |
| 19 | 26045104 | Antimicrobial Sulfated Glycans: Structure and Function. | Curr Top Med Chem | 2017 | https://conductscience.org/library/papers/26045104 | PubMed |
| 20 | 8071336 | Sulfated fucans from echinoderms have a regular tetrasaccharide repeating unit defined by specific patterns of sulfation at the 0-2 and 0-4 positions. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8071336 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41881216 | Marine sulfated glycan inhibits tau-heparan sulfate interaction and tau cellular uptake. | Int J Biol Macromol | 2026 | https://conductscience.org/library/papers/41881216 | PubMed |
| 41735426 | Binding properties of marine sulfated glycans to coagulation (co)-factors using surface plasmon resonance spectroscopy. | Sci Rep | 2026 | https://conductscience.org/library/papers/41735426 | PubMed |
| 41311803 | Antiviral activity of natural and modified hydrocolloids: main sources, susceptible viruses, structure-activity relationship and mechanisms of action. | Front Nutr | 2025 | https://conductscience.org/library/papers/41311803 | PubMed |
| 40872300 | Antiviral Activity of Haematococcus pluvialis Algae Extract Is Not Exclusively Due to Astaxanthin. | Pathogens | 2025 | https://conductscience.org/library/papers/40872300 | PubMed |
| 40564190 | Applications of Surface Plasmon Resonance in Heparan Sulfate Interactome Research. | Biomedicines | 2025 | https://conductscience.org/library/papers/40564190 | PubMed |
| 39958265 | Sustainable and biocompatible hybrid materials-based sulfated polysaccharides for biomedical applications: a review. | RSC Adv | 2025 | https://conductscience.org/library/papers/39958265 | PubMed |
| 39680336 | Inhibition of sulfated glycans on the binding of dengue virus envelope protein to heparin. | Glycoconj J | 2024 | https://conductscience.org/library/papers/39680336 | PubMed |
| 39517244 | Marine-Derived Fucose-Containing Carbohydrates: Review of Sources, Structure, and Beneficial Effects on Gastrointestinal Health. | Foods | 2024 | https://conductscience.org/library/papers/39517244 | PubMed |
| 38728056 | Electrochemical Immunoassay Platform for Human Monkeypox Virus Detection. | Anal Chem | 2024 | https://conductscience.org/library/papers/38728056 | PubMed |
| 38642280 | Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant. | Glycoconj J | 2024 | https://conductscience.org/library/papers/38642280 | PubMed |
| 38400013 | Sulfated Glycans Inhibit the Interaction of MERS-CoV Receptor Binding Domain with Heparin. | Viruses | 2024 | https://conductscience.org/library/papers/38400013 | PubMed |
| 38273842 | Inhibition of adenovirus transport from the endosome to the cell nucleus by rotenone. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38273842 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| DPP4 | 1803 | PubTator's text mining | https://conductscience.org/library/genes/1803 | NCBI Gene |
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| NEU1 | 4758 | PubTator's text mining | https://conductscience.org/library/genes/4758 | NCBI Gene |
| SERPIND1 | 3053 | PubTator's text mining | https://conductscience.org/library/genes/3053 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36959228
GET https://conductscience.org/api/papers/v1/36959228/references?page=2